Plimoth Trust Co. LLC purchased a new position in shares of Cigna Group (NYSE:CI - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 4,476 shares of the health services provider's stock, valued at approximately $1,473,000.
Several other institutional investors and hedge funds have also modified their holdings of CI. Brighton Jones LLC boosted its holdings in Cigna Group by 9.3% in the 4th quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider's stock valued at $1,032,000 after purchasing an additional 318 shares during the period. Allworth Financial LP raised its position in shares of Cigna Group by 5.2% during the fourth quarter. Allworth Financial LP now owns 6,097 shares of the health services provider's stock valued at $1,762,000 after buying an additional 303 shares during the last quarter. Americana Partners LLC lifted its stake in shares of Cigna Group by 32.1% in the fourth quarter. Americana Partners LLC now owns 1,234 shares of the health services provider's stock valued at $341,000 after buying an additional 300 shares during the period. Sanctuary Advisors LLC grew its position in Cigna Group by 2.5% during the fourth quarter. Sanctuary Advisors LLC now owns 50,099 shares of the health services provider's stock worth $14,177,000 after buying an additional 1,239 shares in the last quarter. Finally, CIBC Asset Management Inc grew its position in Cigna Group by 3.4% during the fourth quarter. CIBC Asset Management Inc now owns 42,843 shares of the health services provider's stock worth $11,831,000 after buying an additional 1,411 shares in the last quarter. Institutional investors and hedge funds own 86.99% of the company's stock.
Cigna Group Stock Down 0.2%
Shares of NYSE CI traded down $0.54 during trading hours on Friday, hitting $313.86. The company had a trading volume of 447,730 shares, compared to its average volume of 1,711,052. Cigna Group has a 1-year low of $262.03 and a 1-year high of $370.83. The company has a quick ratio of 0.72, a current ratio of 0.72 and a debt-to-equity ratio of 0.65. The firm's 50 day moving average is $321.79 and its 200-day moving average is $307.93. The stock has a market capitalization of $83.84 billion, a P/E ratio of 17.38, a price-to-earnings-growth ratio of 0.93 and a beta of 0.44.
Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings results on Friday, May 2nd. The health services provider reported $6.74 EPS for the quarter, beating analysts' consensus estimates of $6.35 by $0.39. The firm had revenue of $65.45 billion during the quarter, compared to analysts' expectations of $60.39 billion. Cigna Group had a net margin of 1.97% and a return on equity of 18.63%. The company's revenue for the quarter was up 14.4% compared to the same quarter last year. During the same quarter last year, the company posted $6.47 earnings per share. On average, analysts expect that Cigna Group will post 29.77 earnings per share for the current fiscal year.
Cigna Group Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, June 18th. Shareholders of record on Tuesday, June 3rd were paid a $1.51 dividend. The ex-dividend date was Tuesday, June 3rd. This represents a $6.04 annualized dividend and a yield of 1.92%. Cigna Group's dividend payout ratio is 33.44%.
Analyst Upgrades and Downgrades
A number of brokerages have commented on CI. Royal Bank Of Canada reiterated an "outperform" rating and issued a $371.00 price objective on shares of Cigna Group in a research report on Tuesday, June 3rd. Cantor Fitzgerald raised their target price on Cigna Group from $350.00 to $365.00 and gave the stock an "overweight" rating in a research report on Thursday, March 20th. Morgan Stanley boosted their price target on shares of Cigna Group from $379.00 to $390.00 and gave the company an "overweight" rating in a report on Monday, May 5th. Barclays reaffirmed an "overweight" rating and set a $385.00 price objective (up from $382.00) on shares of Cigna Group in a report on Monday, June 2nd. Finally, Wall Street Zen upgraded shares of Cigna Group from a "buy" rating to a "strong-buy" rating in a research report on Tuesday, April 8th. Two investment analysts have rated the stock with a hold rating, sixteen have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, Cigna Group has a consensus rating of "Buy" and a consensus target price of $380.39.
View Our Latest Analysis on CI
About Cigna Group
(
Free Report)
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Further Reading
Before you consider Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.
While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
